Strong global surveillance through CDC and WHO systems shows no novel pathogen achieving sustained human-to-human transmission capable of triggering a pandemic declaration in 2026, with COVID-19 remaining at low endemic levels, H5N1 avian influenza limited to sporadic cases without efficient spread, and regional outbreaks such as mpox clade I or Bundibugyo Ebola contained geographically. Enhanced genomic sequencing, early-warning networks, and the 2025 WHO Pandemic Agreement have reduced escalation risks compared to historical baselines. Trader consensus at 94.5% probability for no new pandemic aligns with this evidence, though realistic challenges include undetected zoonotic spillovers or viral reassortment in animal reservoirs that could enable rapid international transmission before year-end.